Diclegis
Evidence mounts yet again against efficacy of common morning sickness pill
January 18, 2018Research and Development Diclegis, morning sickness, pharma
Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine (Diclegis, Diclectin), as new study data reveals …
Morning sickness pill scientific backing called into question
January 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness
Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …
FDA warns drugmaker over Kim Kardashian West promo
August 12, 2015Sales and Marketing Diclegis, Duchesnay, FDA, kim kardashian
Model and media personality Kim Kardashian West’s social media promotion of the morning sickness drug Diclegis has landed its producer …
Latest content
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
Danish medical cannabis use rises as regulator reports no new safety signals
September 21, 2026
